Vasectomy Reversal: Vasovasostomy & Vasoepididymostomy — Procedure Guide, Recovery & Risks | MyMedicPlus

Vasectomy reversal is a microsurgical procedure that re-establishes continuity of the vas deferens — the bilateral muscular tubes that transport sperm from the epididymis to the ejaculatory duct — to restore sperm flow to the ejaculate after a previous vasectomy. Two microsurgical techniques are used, selected based on the operative findings at the time of reversal: vasovasostomy (VV), in which the two cut ends of the vas deferens are anastomosed end-to-end, is appropriate when sperm are found in the vasal fluid at the time of reversal; and epididymovasostomy (EV), in which the vas deferens is anastomosed directly to the epididymal tubule proximal to a secondary epididymal obstruction, is required when no sperm are found in the vasal fluid despite the anastomosis being technically patent — indicating that epididymal back-pressure from the vasectomy has caused secondary obstruction further up the epididymis. Vasectomy reversal is the only treatment that simultaneously restores natural fertility and allows natural conception through intercourse without requiring invasive IVF procedures; when successful, it enables multiple conceptions from a single reversal surgery, making it cost-effective compared to repeated IVF cycles. Success rates are time-dependent: they decline progressively with increasing interval from vasectomy, primarily because epididymal back-pressure causes progressive tubular wall thickening, intraluminal fibrosis, and ultimately secondary obstruction in the epididymis.

Vasectomy reversal is suitable for men who have previously undergone vasectomy and wish to restore natural fertility — most commonly following change in relationship, loss of a child, or changed family plans. Ideal candidates are men within 10 years of their vasectomy, where sperm return rates and spontaneous pregnancy rates are highest. Candidates should have no other identified male fertility issues unrelated to the vasectomy, and the female partner should have adequate ovarian reserve and no significant fertility barriers. Couples should be counselled that success rates decline significantly with time: patency rates are approximately 75–90% within 3 years of vasectomy, falling to 55–70% at 3–8 years, and 30–40% beyond 9 years. The alternative of sperm retrieval combined with IVF-ICSI should be discussed and costed alongside reversal to allow informed decision-making. Reversal is not appropriate when female partner fertility issues make natural conception unlikely.

Under general or spinal anaesthesia, two small transverse scrotal incisions (2-4 cm each) are made over the site of each vasectomy. The vas deferens is identified on each side, delivered through the incision, and the scarred vasectomy site is excised until healthy mucosa and lumen are confirmed on frozen section or direct visualisation. Vasal fluid is expressed from the testicular end of the vas and examined under microscopy: the presence of motile sperm confirms the epididymis is patent and vasovasostomy can proceed. The absence of sperm — particularly with thick toothpaste-like fluid — indicates secondary epididymal obstruction requiring epididymovasostomy, which is a technically more challenging procedure performed under 25-40x operating microscope magnification. For vasovasostomy under 15-25x magnification: the two cut ends of the vas are spatulated (angled cuts to widen the anastomosis) and approximated over a fine suture placed in the mucosal layer using 9-0 or 10-0 monofilament nylon (inner layer, 6-8 sutures) followed by a reinforcing outer muscular layer using 6-0 nylon (8-10 sutures). The completed anastomosis creates a watertight lumen-to-lumen connection. For epididymovasostomy: under 25-40x magnification, a single dilated epididymal tubule containing sperm is identified in the epididymis and opened precisely with a microknife or laser. The vasal lumen is anastomosed to the opened tubule using a 10-0 intussusception technique (two-stitch tubuloluminal anastomosis), drawing the epididymal mucosa into the vasal lumen. Total operative time is 2-4 hours for bilateral vasovasostomy; 3-5 hours for bilateral epididymovasostomy.

Vasectomy reversal achieved by vasovasostomy restores sperm to the ejaculate in 80–90% of men reversed within 3 years of vasectomy (patency rates), with spontaneous pregnancy rates of approximately 75% within 3 years. Vasoepididymostomy has lower patency rates of 40–65% reflecting the greater technical challenge, but remains the only option when secondary epididymal obstruction is present. Successful reversal avoids the need for repeated surgical sperm retrieval procedures and costly IVF-ICSI cycles that would otherwise be required. Natural conception after reversal is substantially cheaper overall than IVF when female partner fertility is normal. When reversal achieves patency, sperm quality continues to improve for 6–12 months as the reproductive tract heals and anti-sperm antibody levels fall, improving the chances of spontaneous pregnancy progressively over time.

Surgical risks include haematoma formation requiring drainage (3–5%), wound infection, epididymitis, and scrotal oedema resolving over 3–4 weeks. Intraoperatively, the finding of no sperm in the vasal fluid necessitates the more complex vasoepididymostomy — patients must consent to this possibility preoperatively, as it significantly increases operating time and requires specialised surgical expertise. Even with technically perfect anastomosis confirmed by post-operative semen analysis showing sperm return, spontaneous pregnancy may not occur due to high anti-sperm antibody titres, sperm functional impairment from prolonged obstruction, or unidentified female fertility factors. Anti-sperm antibodies detected in approximately 70% of men after vasectomy can reduce sperm motility and penetration of the egg, lowering pregnancy rates even when patency is restored. Anaesthetic risks are standard for day-case procedures. Reversal failure (no sperm return) necessitates surgical sperm retrieval and IVF-ICSI as the only remaining fertility option.

Patients are discharged the same day following reversal. Scrotal support underwear and intermittent ice packs for the first 48 hours minimise swelling and discomfort. Analgesics (paracetamol, ibuprofen) manage post-operative pain for the first 3–5 days. Sedentary work may resume in 3–5 days; physical labour and heavy lifting are restricted for 3–4 weeks. Sexual activity and ejaculation resume at 4 weeks post-operatively. The first semen analysis is performed 6–8 weeks after reversal to confirm sperm return. If sperm are absent at 3 months post-reversal, the anastomosis has likely failed. Sperm counts typically continue to rise and quality improves over 6–12 months. Regular semen analyses at 3, 6, and 12 months monitor recovery. If patency is confirmed but pregnancy has not occurred within 12–18 months of reversal despite regular unprotected intercourse, female partner evaluation and further fertility investigation are recommended.